Notice2023-07439
National Institute on Alcohol Abuse and Alcoholism; Notice of Meeting
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
April 10, 2023
Issuing agencies
Health and Human Services DepartmentNational Institutes of Health
Full Text
<html>
<head>
<title>Federal Register, Volume 88 Issue 68 (Monday, April 10, 2023)</title>
</head>
<body><pre>
[Federal Register Volume 88, Number 68 (Monday, April 10, 2023)]
[Notices]
[Pages 21200-21201]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2023-07439]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute on Alcohol Abuse and Alcoholism; Notice of
Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of a meeting of the National Advisory
Council on Alcohol Abuse and Alcoholism.
The meeting will be open to the public as indicated below, with
attendance limited to space available. Individuals who plan to attend
and need special assistance, such as sign language interpretation or
other reasonable accommodations, should notify the Contact Person
listed below in advance of the meeting. The open session will be
videocast and can be accessed from the NIH Videocasting and Podcasting
website (<a href="http://videocast.nih.gov/">http://videocast.nih.gov/</a>).
A portion of this meeting will be closed to the public in
accordance with
[[Page 21201]]
the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Advisory Council on Alcohol Abuse
and Alcoholism.
Date: May 9, 2023.
Closed: 10:00 a.m. to 10:45 a.m.
Agenda: To review and evaluate grant applications.
Open: 11:00 a.m. to 3:30 p.m.
Agenda: Presentations and other business of the Council.
Place: National Institutes of Health, National Institute on
Alcohol Abuse and Alcoholism, Conference Rooms A, B & C, 6700B
Rockledge Drive, Bethesda, MD 20817.
Contact Person: Ranga V. Srinivas, Ph.D., Acting Executive
Secretary, National Advisory Council, Extramural Project Review
Branch, National Institute on Alcohol Abuse and Alcoholism, National
Institutes of Health, 6700 B Rockledge Drive, Room 2114, Bethesda,
MD 20892, (301) 451-2067, <a href="/cdn-cgi/l/email-protection#0a79786364637c6b784a676b636624646362246d657c"><span class="__cf_email__" data-cfemail="97e4e5fef9fee1f6e5d7faf6fefbb9f9feffb9f0f8e1">[email protected]</span></a>.
Name of Committee: National Advisory Council on Alcohol Abuse
and Alcoholism, National Cancer Advisory Board, and National
Advisory Council on Drug Abuse.
Date: May 10, 2022.
Open: 10:00 a.m. to 3:30 p.m.
Agenda: Presentation of NIAAA, NCI, and NIDA Director's Update,
Scientific Reports, and other topics within the scope of the
Collaborative Research on Addiction at NIH (CRAN).
Place: National Institutes of Health, National Institute on
Alcohol Abuse and Alcoholism, Conference Rooms A, B & C, 6700B
Rockledge Drive, Bethesda, MD 20817.
Contact Person: Ranga V. Srinivas, Ph.D., Acting Executive
Secretary, National Advisory Council, Extramural Project Review
Branch, National Institute on Alcohol Abuse and Alcoholism, National
Institutes of Health, 6700 B Rockledge Drive, Room 2114, Bethesda,
MD 20892, (301) 451-2067, <a href="/cdn-cgi/l/email-protection#92e1e0fbfcfbe4f3e0d2fff3fbfebcfcfbfabcf5fde4"><span class="__cf_email__" data-cfemail="1764657e797e617665577a767e7b39797e7f39707861">[email protected]</span></a>.
Paulette S. Gray, Ph.D., Director, Division of Extramural
Activities, National Cancer Institute, National Institutes of
Health, 9609 Medical Center Drive, Room 7W444, Bethesda, MD 20892,
240-276-6340, <a href="/cdn-cgi/l/email-protection#b8dfcad9c1c8f8dcddd996d6dbd196d6d1d096dfd7ce"><span class="__cf_email__" data-cfemail="264154475f56664243470848454f08484f4e08414950">[email protected]</span></a>.
Susan Weiss, Ph.D., Director, Division of Extramural Research,
National Institute on Drug Abuse, National Institutes of Health,
6001 Executive Boulevard, NSC, Room 5274, Bethesda, MD 20892, 301-
443-6487, <a href="/cdn-cgi/l/email-protection#01727664687272416f6865602f6f68692f666e77"><span class="__cf_email__" data-cfemail="651612000c1616250b0c01044b0b0c0d4b020a13">[email protected]</span></a>.
Any interested person may file written comments with the committee
by forwarding the statement to the Contact Person listed on this
notice. The statement should include the name, address, telephone
number and when applicable, the business or professional affiliation of
the interested person.
Information is also available on the Institute's/Center's home
page: <a href="http://www.niaaa.nih.gov/AboutNIAAA/AdvisoryCouncil/Pages/default.aspx">http://www.niaaa.nih.gov/AboutNIAAA/AdvisoryCouncil/Pages/default.aspx</a>, where an agenda and any additional information for the
meeting will be posted when available.
Additional Health and Safety Guidance: Before attending a meeting
at an NIH facility, it is important that visitors review the NIH COVID-
19 Safety Plan at <a href="https://ors.od.nih.gov/sr/dohs/safety/NIH-covid-19-safety-plan/Pages/default.aspx">https://ors.od.nih.gov/sr/dohs/safety/NIH-covid-19-safety-plan/Pages/default.aspx</a> for information about requirements and
procedures for entering NIH facilities, especially when COVID-19
community levels are medium or high. In addition, the Safer Federal
Workforce website has FAQs for visitors at <a href="https://www.saferfederalworkforce.gov/faq/visitors/">https://www.saferfederalworkforce.gov/faq/visitors/</a>. Please note that if an
individual has a COVID-19 diagnosis within 10 days of the meeting, that
person must attend virtually. (For more information, please read NIH's
Requirements for Persons after Exposure at <a href="https://ors.od.nih.gov/sr/dohs/safety/NIH-covid-19-safety-plan/COVID-assessment-testing/Pages/persons-after-exposure.aspx">https://ors.od.nih.gov/sr/dohs/safety/NIH-covid-19-safety-plan/COVID-assessment-testing/Pages/persons-after-exposure.aspx</a> and What Happens When Someone Tests
Positive at <a href="https://ors.od.nih.gov/sr/dohs/safety/NIH-covid-19-safety-plan/COVID-assessment-testing/Pages/test-positive.aspx">https://ors.od.nih.gov/sr/dohs/safety/NIH-covid-19-safety-plan/COVID-assessment-testing/Pages/test-positive.aspx</a>.) Anyone from
the public can attend the open portion of the meeting virtually via the
NIH Videocasting website (<a href="http://videocast.nih.gov">http://videocast.nih.gov</a>). Please continue
checking these websites, in addition to the committee website listed
below, for the most up to date guidance as the meeting date approaches.
(Catalogue of Federal Domestic Assistance Program Nos. 93.273,
Alcohol Research Programs, National Institutes of Health, HHS)
Dated: April 5, 2023.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2023-07439 Filed 4-7-23; 8:45 am]
BILLING CODE 4140-01-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on April 10, 2023.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.